Related references
Note: Only part of the references are listed.Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1
Masakazu Miyamoto et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Identification of potential biomarkers related to glioma survival by gene expression profile analysis
Justin Bo-Kai Hsu et al.
BMC MEDICAL GENOMICS (2019)
Identifying Epistasis in Cancer Genomes: A Delicate Affair
Joris van de Haar et al.
CELL (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
Elijah J. Mun et al.
CLINICAL CANCER RESEARCH (2018)
KEGG: new perspectives on genomes, pathways, diseases and drugs
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Precision Oncology: The Road Ahead
Daniela Senft et al.
TRENDS IN MOLECULAR MEDICINE (2017)
Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles
Xing Zhang et al.
ONCOTARGETS AND THERAPY (2017)
Characteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression
Emelie Perland et al.
OPEN BIOLOGY (2017)
Prediction and Analysis of Key Genes in Glioblastoma Based on Bioinformatics
Hao Long et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Differential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survival
Yu-Chiao Chiu et al.
BMC BIOINFORMATICS (2017)
Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review
Ron Batash et al.
CURRENT MEDICINAL CHEMISTRY (2017)
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
F. Bernard-Arnoux et al.
NEURO-ONCOLOGY (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
A comprehensive profile of recurrent glioblastoma
B. Campos et al.
ONCOGENE (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
SV2B is essential for the integrity of the glomerular filtration barrier
Yoshiyasu Fukusumi et al.
LABORATORY INVESTIGATION (2015)
Analysis of gene expression profiles associated with glioma progression
Guozhang Hu et al.
MOLECULAR MEDICINE REPORTS (2015)
Identification of a Novel Fusion Gene Involving RUNX1 and the Antisense Strand of SV2B in a BCR-ABL1-Positive Acute Leukemia
Amelie Giguere et al.
GENES CHROMOSOMES & CANCER (2013)
Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma
M. de Groot et al.
NEUROLOGY (2011)
Loss of the Synaptic Vesicle Protein SV2B Results in Reduced Neurotransmission and Altered Synaptic Vesicle Protein Expression in the Retina
Catherine W. Morgans et al.
PLOS ONE (2009)
Synaptic vesicle protein 2 binds adenine nucleotides
Jia Yao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype
Per Bumming et al.
ENDOCRINE-RELATED CANCER (2007)
SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment
M Lezzi et al.
JOURNAL OF CELL SCIENCE (2005)
Molecular characterization of prostatic small-cell neuroendocrine carcinoma
N Clegg et al.
PROSTATE (2003)
Expression of synaptic vesicle protein 2 (SV2) in neuroendocrine tumours of the gastrointestinal tract and pancreas
AM Jakobsen et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
